TCR-T cells for post-HCT leukemia recurrence; platelets are the predominant source of procoagulant membranes in hemostasis; BR + R maintenance for MCL

In this week's episode we'll discuss HA-1-targeted T-cell receptor T-cell therapy for recurrent leukemia after hematopoietic stem cell transplantation. Next, we'll learn about how 4D intravital imaging in mice reveals the key role of platelets as a source of procoagulant membranes in hemostasis. Finally, we'll hear about modifications to a common induction and maintenance treatment for treatment-naïve mantle-cell lymphoma.

Featured Articles

• HA-1–targeted T-cell receptor T-cell therapy for recurrent leukemia after hematopoietic stem cell
  transplantation
• 4D intravital imaging studies identify platelets as the predominant cellular procoagulant surface in a mouse
  hemostasis model
• Randomized study of induction with bendamustine-rituximab ± bortezomib and maintenance with
  rituximab ± lenalidomide for MCL